2018 Outlook: Biosimilar Trends To Watch

Did The 2017 Biosimilar Industry Pave The Way For A Productive 2018?

Value-added medicines: how repurposed medicines bring value to patients and pharmacists

Pharmacovigilance, traceability and building trust in biosimilar medicines

Manufacturing cost transparency could combat pricing criticism, says expert

Medicines for Europe llama a poner en marcha políticas para evitar desabastecimientos

Europe needs change to drive added value

European report calms common concerns

País pode poupar “mais 100 milhões por ano” com genéricos

Europäer zahlen zu viel für Pillen